The field of pharmacophore modeling has steadily emerged as a cornerstone in the rational design of kinase inhibitors. By abstracting the essential molecular features required for optimal binding to ...
Quantum computing systems and software company D-Wave Quantum Inc. has partnered with the pharmaceutical division of Japan Tobacco Inc. to build a proof-of-concept artificial intelligence model using ...
A researcher has proposed a more targeted approach to AI drug discovery, which includes a rigorous evaluation protocol.
Researchers from the Massachusetts Institute of Technology (MIT) Jameel Clinic for Machine Learning in Health have announced the open-source release of Boltz-2, which now predicts molecular binding ...
The drug development pipeline is a costly and lengthy process. Identifying high-quality "hit" compounds—those with high ...
(Reuters) -Bristol Myers Squibb, Takeda Pharmaceuticals and Astex Pharmaceuticals are coming together to share proprietary data for training an artificial intelligence model to assist drug discovery ...
Research and drug discovery are undergoing a transformation, driven by the rise of 3D cell culture models that better replicate human biology. Unlike traditional 2D cultures and animal models, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback